Signal86ae409c

WEBINDEXED

Ex-FDA Principal Deputy Commissioner Amy Abernethy joined Verily (Alphabet) in 2020 post-oncology approvals amid $50M tech-health lobbying.

Author:statnews.com

Published:2020-01-31 00:00 UTC

Occurred:2020-01-31 00:00 UTC

Received:2026-04-09 08:00 UTC

Status Score

91%

ITG

96%

IMP

86%

NAR

80%

Analysis Insights

Topics Detected

#Revolving Door#Healthcare Tech

Entities Mentioned

@Amy Abernethy@FDA@Verily@Alphabet

Technical Details

Analyst Mission

Corporate Lobbying Trackera76754d3...

Source IDN/A

Original URLhttps://www.statnews.com/2020/01/31/amy-abernethy-leaving-fda-for-verily/

Database ID86ae409c-c26f-453d-ac57-8c0db9c5b6e4

Raw Data

{
  "id": "86ae409c-c26f-453d-ac57-8c0db9c5b6e4",
  "content": "Ex-FDA Principal Deputy Commissioner Amy Abernethy joined Verily (Alphabet) in 2020 post-oncology approvals amid $50M tech-health lobbying.",
  "url": "https://www.statnews.com/2020/01/31/amy-abernethy-leaving-fda-for-verily/",
  "source_type": "web",
  "source_id": null,
  "author_id": "statnews.com",
  "published_at": "2020-01-31T00:00:00.000Z",
  "received_at": "2026-04-09T08:00:39.523Z",
  "status": "indexed",
  "relevance_score": 91,
  "case_id": null,
  "metadata": {
    "topics": [
      "Revolving Door",
      "Healthcare Tech"
    ],
    "mission": "Corporate Lobbying Tracker",
    "mentions": [
      "Amy Abernethy",
      "FDA",
      "Verily",
      "Alphabet"
    ],
    "mission_id": "a76754d3-444f-44d8-bf31-a548a575182e"
  },
  "credibility_score": 96,
  "actionability_score": 86,
  "emotional_score": 80,
  "occurred_at": "2020-01-31T00:00:00.000Z",
  "case_ids": null
}